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Abstract
Congenital anomalies of the kidney and urinary tract (CAKUT) account for approximately half of
children with chronic kidney disease. CAKUT can be caused by monogenic mutations, however,
data are lacking on their frequency. Genetic diagnosis has been hampered by genetic heterogeneity
and lack of genotype-phenotype correlation. To determine the percentage of cases with CAKUT
that can be explained by mutations in known CAKUT genes, we analyzed the coding exons of the
17 known dominant CAKUT-causing genes in a cohort of 749 individuals from 650 families with
CAKUT. The most common phenotypes in this CAKUT cohort were 288 with vesicoureteral
reflux, 120 with renal hypodysplasia and 90 with unilateral renal agenesis. We identified 37
different heterozygous mutations (33 novel) in 12 of the 17 known genes in 47 patients from 41 of
the 650 families (6.3%). These mutations include (number of families): BMP7 (1), CDC5L (1),
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tCHD1L (5), EYA1 (3), GATA3 (2), HNF1B (6), PAX2 (5), RET (3), ROBO2 (4), SALL1 (9), SIX2
(1), and SIX5 (1). Furthermore, several mutations previously reported to be disease-causing are
most likely benign variants. Thus, in a large cohort over 6% of families with isolated CAKUT are
caused by a mutation in 12 of 17 dominant CAKUT genes. Our report represents one of the most
in-depth diagnostic studies of monogenic causes of isolated CAKUT in children.
Keywords
renal agenesis; renal development; genetic renal disease
INTRODUCTION
Congenital anomalies of kidney and urinary tract (CAKUT) are observed in 3–6 per 1,000
live births and account for 40–50% of the etiology of chronic kidney disease (CKD) in
children worldwide1, 2. CAKUT cover a wide range of structural malformations that result
from a defect in the morphogenesis of the kidney and/or the urinary tract3–5. The condition
may appear as an isolated feature or as part of a syndrome in association with extra-renal
manifestations6, 7. In addition, CAKUT may either be diagnosed sporadically or was
described with familial aggregation in up to 15% of cases8, 9. In familial cases, the mode of
inheritance in most pedigrees is autosomal dominant with variable expressivity and reduced
penetrance10. The pathogenesis of CAKUT is based on the disturbance of normal
nephrogenesis, and can be due to genetic abnormalities in renal developmental genes that
direct the process1, 3–5, 11–13. To date, about 20 monogenic CAKUT causing genes have
been identified to result in isolated CAKUT or syndromic CAKUT with mild extra-renal
manifestations14–34. Only a few studies have screened large cohorts of CAKUT patients for
disease-causing mutations35–40. These studies screened for 1–5 disease-causing genes and
some were pre-selected for chronic renal insufficiency or severe disease phenotypes35–37.
Hence, data are lacking on the frequency of monogenic forms of CAKUT in large cohorts.
To address these issues we investigated the frequency of mutations in 17 known dominant
CAKUT-causing genes in a phenotypically non-selective international cohort of 749
CAKUT individuals out of 650 different families. We show that mutations in known
CAKUT-causing genes are present in more than 6% of these families, and we outline
possible pitfalls in analyzing autosomal dominant single-gene disorders.
RESULTS
Our cohort of 749 individuals from 650 different families with CAKUT originated from
Eastern Europe (63.6%), Western Europe (12.7%), Arab countries (10%), India (7.9%),
Roma populations (1.5%), and Asia (0.7%) (Supplementary Table S1). There were 414 male
(55%) and 331 female (44.2%) individuals. The most common CAKUT phenotype was
vesicoureteral reflux (n=288), followed by renal hypodysplasia (n=120) and unilateral renal
agenesis (n=90). One hundred and sixty-one individuals from 100 families are considered as
familial CAKUT according to clinical questionnaires in our cohort. These families have 2 to
6 affected individuals. The most common familial CAKUT phenotypes include
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tvesicoureteral reflux (n=68), duplex system (n=29), followed by renal hypodysplasia
(n=19), and others. For detailed cohort characteristics see Supplementary Table S1.
By targeted re-sequencing of 170 coding exons of 17 genes known to cause autosomal
dominant CAKUT we identified 144,382 single-nucleotide variants (SNVs) and 39,081
insertion-deletion variants in the 650 families. Following our variant filtering as described in
the Methods, we retained 341 variants as potentially deleterious alleles. One hundred fifty-
two of these were confirmed by Sanger sequencing whereas the others represented low-
representation artifacts of multiplex PCR. In order to distinguish benign variants from
disease-causing mutations we carefully evaluated each variant individually based on criteria
as described in the Methods section. Overall 105 variants did not meet our criteria for being
probably disease causing. Among these, 43 variants were previously reported as mutations
in individuals with CAKUT (Supplementary Table S2), and 62 variants were not previously
reported (Supplementary Table S3) in the Human Gene Mutation Database (http://
www.hgmd.cf.ac.uk/ac/index.php).
In 749 patients with CAKUT from 650 families, disease-causing heterogeneous dominant
mutations were identified in 41 unrelated families (6.3%) (Table 1). Mutations were
detected in the following genes: BMP7 (1 family), CDC5L (1 family), CHD1L (5 families),
EYA1 (3 families), GATA3 (2 families), HNF1B (5 families), PAX2 (5 families), RET (3
families), ROBO2 (4 families), SALL1 (9 families), SIX2 (1 family), and SIX5 (1 family)
(Table 1). No causative mutations were identified in the genes SOX17, UMOD, BMP4, SIX1
and UPK3A. In total, 33 of the 37 mutations were novel pathogenic mutations.
DISCUSSION
We here examined a large international cohort of 650 unrelated families with CAKUT for
the presence of mutations in 17 autosomal dominant known CAKUT-causing genes. We
identified 37 different heterozygous mutations in 12 different genes in 41 of the 650 families
(6.3%). Thirty-three of the 37 mutations detected were novel.
Our findings also revealed that some variants previously reported as disease-causing cannot
be accepted as such based on the finding of lack of segregation of these genetic variants in
families with multiple affected individuals. For example, the BMP4 variant p.S91C and the
SIX2 variant p.P241L, have been reported to lead to CAKUT among 5 unrelated patient15.
We detected these two variants among 13 unrelated families in our cohort and five of them
did not segregate with the disease, i.e. not all affected family members have the variant.
These findings reveal that these two variants cannot be considered as disease-causing. These
findings encourage us to adhere to our strict definition of disease-causing variants as
outlined in ‘Methods’ and are consistent with the findings that many alleles published as
disease-causing may not reliably have such a role41, 42. We found that 9 variants (43
individuals) in previously CAKUT-related publications and 50 HGMD-unreported variants
(62 individuals) did not fulfill our criteria (Supplementary Tables S2 and S3, respectively).
This work, to the best of our knowledge, is the most extensive genetic screening of known
CAKUT-causing genes. SALL1, HNF1B and PAX2 were the most prevalent disease causing
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tgenes in our cohort. This is in line with the predominance of HNF1B and PAX2 mutations
that has been described in patients with renal hypodysplasia35, 36, 38. HNF1B and PAX2
were previously reported to be disease-causing in 5–20% of CAKUT cases35–40. The finding
that PAX2 and HNF1B mutations were seen at higher frequency in previous studies on
CAKUT is most likely explained by the fact that these studies use CAKUT cohorts
preselected for CKD and in prenatal findings with severe renal anomalies35–37. Our data are
consistent with previous publications describing that oligosyndromic CAKUT-causing genes
can lead to an isolated CAKUT phenotype35.
The fact that we did not identify mutations in SOX17, UMOD, BMP4, SIX1, and UPK3A
suggests that mutations in those genes are rarer. The identification of SALL1 mutations > 1%
of our cohort, suggests that this gene may be more common cause of CAKUT than
previously believed35. It should be emphasized that in the current study we did not screen
our cohort for copy number variations. It was previously shown that some of the known
CAKUT-causing genes may be disrupted by deletions or duplications, such as heterozygous
HNF1B deletion35. Moreover, in a recent study involving 522 patients with CAKUT, 72
distinct known or novel copy-number variations in 87 (16.6%) patients were identified,
suggesting that kidney malformations can, in part, result from pathogenic genomic
imbalances43.
Our study supports the observation that CAKUT is a genetically very heterogeneous disease
with diverse clinical phenotypes. We provide further evidences that the role of specific
oligosyndromic CAKUT genes (i.e. SALL1) have a higher contribution in CAKUT than
previous thought. The numbers of known CAKUT genes are expanding with the recent
discovery of several novel genes, including FGF20, TNXB, WNT4, and DSTYK31–34, which
were not included in our study because they were described after completion of our study.
We expect the list of CAKUT-causing genes to keep growing with the increasing application
of next generation sequencing techniques. Identification of the monogenetic causes of
CAKUT will have important implications in assessing the risk towards progression into end-
stage renal disease (ESRD), for this group of diseases that causes ~50% of all ESRD in the
first two decades of life.
MATERIALS AND METHODS
Human subjects
We obtained blood samples and pedigrees following informed consent from individuals with
CAKUT. The study was approved by the institutional review board of the University of
Michigan Medical School and Boston Children’s Hospital. Patients were included in the
study if a diagnosis compatible with CAKUT was established by a pediatric nephrologist
investigator. The study comprised 749 individuals from 650 families with CAKUT from 25
different pediatric nephrology units worldwide (see Supplementary Table 1). Excluded from
the study were patients with CAKUT associated with prominent involvement of other
organs (syndromic CAKUT).
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DNA was extracted according to standard method from peripheral blood obtained from all
study participants. As previously described by our group35, 39, multiplexed PCR-based
amplified products using Fluidigm Access-Array™ technology followed by barcoding and
next-generation re-sequencing on an Illumina MiSeq platform. Sanger DNA sequencing was
further conducted for single mutation conformation. All coding exons and adjacent splice
sites of the following 17 autosomal dominant genes that are known to cause non-syndromic
or oligo-syndromic CAKUT were screened: BMP4, BMP7, CDC5L, CHD1L, EYA1,
GATA3, HNF1B, PAX2, RET, ROBO2, SALL1, SIX1, SIX2, SIX5, SOX17, UMOD, and
UPK3A.
Primer design
We designed 252 target-specific primer pairs to cover all 170 coding exons and intron/exon
boundaries of the 17 known dominant CAKUT-causing genes (PCR primers are available
upon request). The maximum amplicon size was chosen as 150–300 bp. Universal primer
sequences 5-ACACTGACGACATGGTTCTACA-[target-specific forward]-3′ and 5′-
TACGGTAGCAGAGACTTGGTCT-[target-specific reverse]-3′ were added at the 5′ end to
all target-specific forward and reverse primers, respectively.
Target DNA enrichment and resequencing
Primers were pooled to generate 6-plex primer pools per PCR with a final concentration of 1
QM per primer. Every sample master mix contained 50 ng genomic DNA, 1X FastStart
High Fidelity Reaction Buffer with MgCl2, 5 % DMSO, dNTPs (200 μM each), “FastStart
High Fidelity Enzyme Blend” and 1X “Access Array” loading reagent (Roche, Indianapolis,
IN). 48 different DNA samples were mixed with 48 different 6-plex primer pools on one
48.48 Access Array™ followed by thermal cycling. Subsequently harvested amplicon pools
were submitted to another PCR-step to tag PCR products with 48 different barcodes and
Illumina sequence-specific adaptors as previously described35, 39. Barcoded PCR products
were pooled from 125 individuals and submitted to next-generation resequencing on an
Illumina MiSeq platform. A total of six 2 x 250 bp paired-end runs of Illumina MiSeq were
performed according to manufacturer’s protocol. Detected variants were confirmed by
Sanger sequencing. Segregation analysis was performed if DNA from family members was
available.
Mutation calling of autosomal dominant genetic variants as likely disease-causing
Read alignment and variant detection was done using CLC Genomics Workbench software
(CLC-bio, Aarhus, Denmark) as described previously by our group35. After applying
filtering criteria, the number of remaining variants (in parenthesis) were as follows: 1) minor
variant frequency <10% (56,410), 2) dbSNP135 with minor allele frequency (MAF) < 1%
(23,491), 3) non-synonymous changes and splice variants (7,252), 4) variant with minor
variant frequency > 30% (2,511), 5) same variant presents in < 5% of the study cohort (341).
We considered variants as probably disease-causing according to the following inclusion
and exclusion criteria:
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tInclusion criteria: (1) truncating mutation (stop-gained, abrogation of obligatory splice site,
frameshift); OR (2) missense mutation if one of the following applied: (a) continuous
evolutionary conservation to D. rerio; OR (b) the given disease causing allele is supported
by functional data.
Exclusion criteria (superseding inclusion criteria): (1) lack of segregation of a “mutant”
allele to all affected family members; (2) no continuous evolutionary conservation to D.
rerio (3) allele is present in the Exome Variant Server (EVS) database.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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